Inventor · disambiguated record
Rodolfo Fleury Perini
Also filed as: PERINI RODOLFO F · PERINI RODOLFO FLEURY
2 granted patents·10 pending applications·21 citations·filing 2014–2023
61Inventor score
Top patents by PatentIndex Score
12 records- 0191US9907849B2Combination of a PD-1 antagonist and a listeria-based vaccine for treating prostate cancerADVAXIS INC·Filed 2015·Granted Mar 6, 2018·10 cites·15 claims
- 0283US10570202B2Combination of a PD-1 antagonist and a VEGFR inhibitor for treating cancerPFIZER·Filed 2015·Granted Feb 25, 2020·11 cites·26 claims
- 0356US2025333509A1Methods for treating cancer, or von-hippel lindau disease using a combination of a tigit antagonist, a pd-1 antagonist, and a hif-2-alpha inhibitorMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 0455US2020325228A1Combination of a pd-1 antagonist and a vegfr inhibitor for treating cancerPFIZER·Filed 2020·Application pending·0 cites
- 0555US2024247065A1Methods of treatment of cancer patients having altered setd2 biomarker with a pd-1 antagonistMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 0647US2016303231A1Treating cancer with a combination of a pd-1 antagonist and a vegfr inhibitorIANNONE ROBERT·Filed 2014·Application pending·0 cites
- 0746US2023250182A1Methods for treating cancer or von-hippel lindau disease using a combination of a pd-1 antagonist, a hif-2 alpha inhibitor, and lenvatinib or a pharmaceutically acceptable salt thereofMERCK SHARP & DOHME LLC·Filed 2021·Application pending·0 cites
- 0846US2024010729A1Combination therapy of a pd-1 antagonist and lag3 antagonist and lenvatinib or a pharmaceutically acceptable salt thereof for treating patients with cancerHEALY JANE ANNE·Filed 2021·Application pending·0 cites
- 0946US2018185483A1Combination of a pd-1 antagonist and a listeria-based vaccine for treating prostate cancerADVAXIS INC·Filed 2018·Application pending·0 cites
- 1045US2023058779A1Combination cancer treatment using a pd-1 antagonist, an ilt4 antagonist, and lenvatinib or salts thereofMERCK SHARP & DOHME LLC·Filed 2020·Application pending·0 cites
- 1145US2023210838A1Methods for treating cancer or von-hippel lindau disease using a combination of a hif-2 alpha inhibitor and lenvatinibMERCK SHARP & DOHME LLC·Filed 2021·Application pending·0 cites
- 1243US2023118596A1Methods for treating cancer using a combination of a pd-1 antagonist, a ctla4 antagonist, and lenvatinib or a pharmaceutically accpetable salt thereofMERCK SHARP & DOHME LLC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Rodolfo Fleury Perini files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →